Engenco Ltd
ASX:EGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Engenco Ltd
ASX:EGN
|
AU |
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
Christian Dior SE
PAR:CDI
|
FR |
|
Gudang Garam Tbk PT
IDX:GGRM
|
ID |
|
Cadeler A/S
OSE:CADLR
|
DK |
|
E
|
Euroapi SAS
PAR:EAPI
|
FR |
|
Fulcrum Therapeutics Inc
NASDAQ:FULC
|
US |
|
D
|
Daseke Inc
F:1VG
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EGN's stock price target?
Not Available
EGN doesn't have any price targets made by Wall Street professionals.
What is Engenco Ltd's Revenue forecast?
Projected CAGR
-3%
For the last 13 years the
compound annual growth rate for
Engenco Ltd's revenue is
1%.
The projected
CAGR
for the next 4 years is
-3%.
What is Engenco Ltd's Operating Income forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Engenco Ltd's operating income is
-9%.
The projected
CAGR
for the next 4 years is
14%.
What is Engenco Ltd's Net Income forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Engenco Ltd's net income is
-2%.
The projected
CAGR
for the next 4 years is
17%.
